Clinical Trials and Research


Research at Ramsay
Ramsay is proud to play a leading role in Australia’s health and medical research sector by driving research through the
Ramsay Research & Development Network, the
Ramsay Hospital Research Foundation, and our
Research Ethics, and
Governance Unit.
The Clinical Trials and Research Unit at John Flynn Private Hospital is part of the Ramsay Research & Development Network that operates across 20+ Ramsay Health Care facilities throughout Australia. Our hospital actively encourages and supports clinical research as a key contributor to improved patient outcomes. We believe that providing early access to promising clinical trials is essential to delivering high-quality, leading-edge care, consistent with the standard of care at our hospital.
Conducting Research
Participating in Research
Current Trials
Conducting Research
Our hospital has a dedicated clinical trials & research unit that supports the conduct of research across all aspects of the hospital. Our site manager and the broader research team can provide advice on how to get involved.
Contact Clinical Trials and Research Manager via email at
clinicaltrials.jfp@ramsayhealth.com.au
All research conducted at John Flynn Private Hospital requires local endorsement, as well as Ethics & Research Governance Approval. If you are interested in conducting research the following steps will need to be taken:

Step 1. Apply for Research Endorsement
This first step allows the hospital to review the proposed research and ensure that it is appropriate to be conducted at the hospital. This guarantees the researcher has confirmation early that the hospital is able to provide the necessary infrastructure, people or access that will be required and once approved, the research will be established seamlessly.
To apply for Research Endorsement, please use this form.
Once completed, applicants should email this form to
clinicaltrials.jfp@ramsayhealth.com.au
This form should be completed by Principal Investigators, Students, or nursing and allied health professionals and our internal research teams. Direct submission of this form from CROs or Industry Sponsors will not be accepted.
Step 2: Research Ethics
Ramsay will accept research ethics approvals from any NHMRC endorsed Human Research Ethics Committee, provided that committee is willing to oversee the research in Ramsay.
Ramsay also maintains a Human Research Ethics Committee who can assist where an applicant has not previously sought ethics approval. Further information about Ramsay’s processes can be found here.
Step 3: Research Governance
It is a requirement of Ramsay Health Care that all research applications receive research governance approval prior to any research commencing at the hospital.
Applications for Research Governance can be submitted through the REGGS platform.
Click here to access REGGS
All questions relating to Research Governance can be directed to the following email address:
ResearchGovernance@ramsayhealth.com.au
or call the Ramsay National Research Unit on (02) 9433 3854.
Participating in Research
If you’re interested in participating in a clinical trial, you may be eligible for one currently being conducted at John Flynn Private Hospital as listed below. Please speak with your doctor to explore your options. If you’re interested in participating in a clinical trial, not offered at John Flynn Private Hospital, your doctor may be able to help you find another trial appropriate for you. Alternatively, you can search for suitable clinical trials through the Australian Clinical Trials website or ClinTrial Refer.
For any inquiries, please contact Clinical Trials and Research Manager via email at clinicaltrials.jfp@ramsayhealth.com.au
Current Trials
| Study Name |
Therapeutic Area |
Recruitment Status |
Lead Investigator |
BCA101x301
Study Details | FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC | ClinicalTrials.gov |
HPV - Head and Neck Cancer |
Currently Recruiting |
Dr David Martin |
BNT113-01
Study Details | A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1 | ClinicalTrials.gov |
HPV + Head and Neck Cancer |
Currently Recruiting |
Dr David Martin |
IOS-1002-201
Study Details | A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of IOS-1002 Administered Alone and in Combination with Pembrolizumab, a PD-1 Monoclonal Antibody in Advanced Solid Tumors | ClinicalTrials.gov |
Advanced Solid Tumours |
Currently Recruiting |
Dr Pawan Bajaj |
DB-1311-O-1001
Study Details | A Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors | ClinicalTrials.gov |
Advanced Solid Tumours |
Currently Recruiting |
Dr David Martin |
DB-1311-201
Study Details | DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors | ClinicalTrials.gov |
Non-Small Cell Lung Cancer, Head and Neck Cancer, Melanoma, Cervical Cancer and Hepatocellular Cancer |
Recruiting soon |
Dr. Pawan Bajaj |
BNT326-02 |
Non-Small Cell Lung Cancer |
Recruiting soon |
Dr. Pawan Bajaj |
GS-US-574-7321
https://clinicaltrials.gov/study/NCT06926920">Study Details | A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer | ClinicalTrials.gov |
Triple Negative Breast Cancer |
Recruiting soon |
Dr. Sumit Lumba |
HRS-5041-103
Study Details | A Trial of HRS-5041-103 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Subjects With Metastatic Castration-resistant Prostate Cancer | ClinicalTrials.gov |
Metastatic Castrate Resistant Prostate Cancer |
Currently Recruiting |
Dr David Martin |
HRS-3802-101
Study Details | Safety, Tolerability, and Pharmacokinetics of HRS-3802 Monotherapy in Patients With Malignant Solid Tumors | ClinicalTrials.gov |
HR+ HER – Breast Cancer |
Recruiting soon |
Dr David Martin |
1378-0020
Study Details | A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure | ClinicalTrials.gov |
Heart failure |
Currently Recruiting |
Dr Ashok Gangasandra Basavaraj |
MT300V-105
ANZCTR - Registration |
Bacterial Vaginosis |
Currently Recruiting |
A/Prof Mikhail Sarofim |
All research activity that is to be undertaken within Ramsay Health Care has both Human Research Ethics Committee (HREC) and Research Governance approval in place.
Governance applications are prepared and submitted through Ramsay Research, Ethics and Governance portal (REGGS).